All Stories

  1. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo, Dr Carmelo Garcia-Monzon , Dr Eduardo EVG Vilar Gomez

  2. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

    Article • Hepatology, January 2017, Wiley

    Dr Carmelo Garcia-Monzon

  3. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones

    Article • Liver International, March 2015, Wiley

    Dr Carmelo Garcia-Monzon